Connor Clark & Lunn Investment Management Ltd. Acquires Shares of 52,168 Kinnate Biopharma Inc. (NASDAQ:KNTE)
Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Kinnate Biopharma Inc. (NASDAQ:KNTE – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 52,168 shares of the company’s stock, valued at approximately […]
More Stories
Border Czar: ICE to Assist at Airports Until They Are 100 Percent, TSA Pay Coming This Week
By Tom Gantert White House border czar Tom Homan said Sunday that ICE agents will be used to help out...
Trump Signals Potential Military Action Coming Against Cuba
By Jack Phillips President Donald Trump again suggested that U.S. military action could be coming against Cuba as his administration...
US Monitoring Surge in China’s Detention of Panama-Flagged Vessels
By Aldgra Fredly The U.S. Federal Maritime Commission on March 26 accused China of detaining Panama-flagged vessels in response to...
FBI Director Kash Patel Hacked by Iran-Linked Group
By Jacki Thrapp FBI Director Kash Patel’s personal email inbox was accessed by Iran-based hackers. “The FBI is aware of...
Block CFO Defends Job Cuts Due to AI Adaptation; Silicon Valley Executives Predict Increased Mass Layoffs
By Dylan Morgan Block’s Chief Financial Officer and Chief Operating Officer Amrita Ahuja defended the San Francisco-based payments company’s mass...
Houthis Enter Iran War With Missile Attack on Israel
By Tom Ozimek A spokesman for the Iran-aligned Houthi terrorist organization in Yemen said on March 28 that the group...